4//SEC Filing
ROMANO KATHRYN 4
Accession 0001801385-25-000002
CIK 0001711279other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:01 PM ET
Size
24.0 KB
Accession
0001801385-25-000002
Insider Transaction Report
Form 4
ROMANO KATHRYN
Chief Accounting Officer
Transactions
- Exercise/Conversion
Performance Stock Units
2025-02-28−5,000→ 0 total→ Common Stock (5,000 underlying) - Award
Stock Option (Right to Buy)
2025-02-28+10,000→ 10,000 totalExercise: $179.25Exp: 2035-02-28→ Common Stock (10,000 underlying) - Award
Restricted Stock Units
2025-02-28+2,200→ 2,200 total→ Common Stock (2,200 underlying) - Tax Payment
Common Stock
2025-02-26$176.39/sh−2,268$400,053→ 13,354 total - Sale
Common Stock
2025-02-27$175.22/sh−750$131,415→ 12,604 total - Exercise/Conversion
Common Stock
2025-02-28+5,000→ 17,604 total - Tax Payment
Common Stock
2025-02-28$179.25/sh−2,315$414,964→ 15,289 total - Exercise/Conversion
Common Stock
2025-02-28+7,500→ 22,789 total - Tax Payment
Common Stock
2025-02-28$179.25/sh−3,471$622,177→ 19,318 total - Exercise/Conversion
Performance Stock Units
2025-02-28−7,500→ 7,500 total→ Common Stock (7,500 underlying)
Footnotes (13)
- [F1]Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2025. 19,600 Restricted Stock Awards ("RSAs) were granted on February 26, 2021, to the Reporting Person. Each RSA represented a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. The RSAs vested in four equal annual installments beginning on February 26, 2022.
- [F10]The option vests in four equal annual installments beginning on February 28, 2026.
- [F11]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date.
- [F12]The number of RSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming the Reporting Person's continued service to the Company on all applicable vesting dates.
- [F13]The RSUs vest in four equal annual installments with the first installment vesting on February 28, 2026.
- [F2]The closing price on February 26, 2025 of the Company's common stock on the Nasdaq Global Select Market.
- [F3]The sale of the shares of the Company's common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on November 18, 2024 and will terminate on the earlier of August 20, 2025 or the date all trades are executed or expire under the Rule 10b5-1 trading plan.
- [F4]The transaction was executed in multiple lots at the same price, $175.22.
- [F5]10,000 performance stock units ("PSUs") were granted on February 28, 2023. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31 2023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. The PSUs vested ratably over a two-year period. All of the performance criteria were achieved and one-half of the PSUs granted, or 5,000 PSUs, vested on February 28, 2024, and the remaining 5,000 PSUs vested on February 28, 2025.
- [F6]Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 5,000 PSUs on February 28, 2025.
- [F7]The closing price on February 28, 2025 of the Company's common stock on the Nasdaq Global Select Market.
- [F8]15,000 PSUs were granted on February 29, 2024. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31 2024, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. The PSUs vest ratably over a two-year period. All of the performance criteria were achieved and one-half of the PSUs granted, or 7,500 PSUs, vested on February 28, 2025.
- [F9]Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 7,500 PSUs on February 28, 2025.
Documents
Issuer
Krystal Biotech, Inc.
CIK 0001711279
Entity typeother
Related Parties
1- filerCIK 0001801385
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:01 PM ET
- Size
- 24.0 KB